Effects of a Beverage Rich in Fruit Extracts on Risk Factors Associated With Cardiovascular Disease

NCT ID: NCT00795834

Last Updated: 2008-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-06-30

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the effects of a novel beverage rich in polyphenols (compounds present in fruit extracts) on risk factors associated with cardiovascular disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will assess the potential of a beverage containing plant and fruit extracts rich in polyphenolics to modulate vascular risk.

Novel risk factors for vascular disease will be assessed including non-invasive assessment of vascular function by pulse wave analysis / pulse wave velocity and laser doppler iontophoresis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

polyphenolics flavonols lipids endothelial function vascular risk factors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Beverage

Group Type PLACEBO_COMPARATOR

Placebo Beverage

Intervention Type DIETARY_SUPPLEMENT

Antioxidant capacity umol TE/L(ORAC): negligible Polyphenolic Content(mcg/ml): negligible Vitamin C (mg/100ml): 0.00 Calorie Content (Kcal/250ml):40.0

250ml twice daily for 1 month (56 doses)

High Polyphenol Beverage

Group Type ACTIVE_COMPARATOR

High polyphenol beverage

Intervention Type DIETARY_SUPPLEMENT

Antioxidant capacity umol TE/L(ORAC): 19987 Polyphenolic Content(mcg/ml): 1445 Vitamin C (mg/100ml): 35.35 Calorie Content (Kcal/250ml):40.0

250ml twice daily for 1 month (56 doses)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High polyphenol beverage

Antioxidant capacity umol TE/L(ORAC): 19987 Polyphenolic Content(mcg/ml): 1445 Vitamin C (mg/100ml): 35.35 Calorie Content (Kcal/250ml):40.0

250ml twice daily for 1 month (56 doses)

Intervention Type DIETARY_SUPPLEMENT

Placebo Beverage

Antioxidant capacity umol TE/L(ORAC): negligible Polyphenolic Content(mcg/ml): negligible Vitamin C (mg/100ml): 0.00 Calorie Content (Kcal/250ml):40.0

250ml twice daily for 1 month (56 doses)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>/= 55 years
* BMI \> 25

Exclusion Criteria

* Present smoker or smoked within the last 2 years
* HBA1C \> 6.0%
* eGFR\<60
* LFT \>/= 3 times upper limit of normal
* Hypertension: systolic blood pressure \> 160mmHg; diastolic blood pressure \> 90mmHg, or on medication for hypertension.
* Chronic disease, likely to be clinically relevant (eg:

cardiorespiratory, rheumatological, cerebrovascular or neoplastic disease)

* Vitamin supplements within the previous 14 days
* Medications which, in the opinion of the investigators, are known to influence vascular function (eg corticosteroids).
Minimum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Glasgow

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Glasgow

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Naveed Sattar, MBChB PhD FRCPath FRCP

Role: PRINCIPAL_INVESTIGATOR

University of Glasgow

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

British Heart Foundation Glasgow Cardiovascular Research Centre

Glasgow, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Adam WF Mullan, MBChB MRCP

Role: CONTACT

Phone: +44-141-330-2569

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Adam Mullan, MBChB BSc MRCP

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Mullan A, Delles C, Ferrell W, Mullen W, Edwards CA, McColl JH, Roberts SA, Lean ME, Sattar N. Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized placebo-controlled trial. Atherosclerosis. 2016 Mar;246:169-76. doi: 10.1016/j.atherosclerosis.2016.01.004. Epub 2016 Jan 6.

Reference Type DERIVED
PMID: 26797134 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RN08BI013

Identifier Type: -

Identifier Source: secondary_id

07/S0704/110

Identifier Type: -

Identifier Source: org_study_id